Alligator Bioscience Stock

Alligator Bioscience Employees 2024

Alligator Bioscience Employees

43

Ticker

ATORX.ST

ISIN

SE0000767188

WKN

A2AN1Z

In 2024, Alligator Bioscience employed 43 people, a 0% change from the 43 number of employees in the previous year.

Alligator Bioscience Aktienanalyse

What does Alligator Bioscience do?

Alligator Bioscience AB is a biopharmaceutical company based in Lund, Sweden. The company was founded in 2001 and specializes in the development of innovative cancer therapies that harness the body's immune system to fight tumor cells. The company's business model is based on the research, development, and commercialization of biological drugs using highly specialized technologies such as antibody research and immuno-oncology. Alligator Bioscience works closely with leading research institutions and partners in the biotechnology and pharmaceutical industries. Its main focus is on developing antibodies against cancer using its patented technology platforms ALLIGATOR-GOLD® and ALLIGATOR-FAB®. These antibodies are highly effective, safe, and have a low side effect profile. Another important area of Alligator Bioscience's work is immuno-oncology, which involves activating and enhancing the body's own immune system to target and destroy cancer cells. The company has developed a range of innovative drugs in various stages of clinical development. One of its key products is ATOR-1017, a monoclonal antibody that targets the OX40 T-cell receptor and has shown promising results in activating the immune system against cancer in clinical trials. ADC-1013, an antibody targeting the PD-1 receptor, is another promising drug in development for the treatment of various types of cancer. Alligator Bioscience has a diverse portfolio of products and drugs focused on fighting cancer and works closely with research partners and customers to improve the effectiveness and safety of its products for market release. In summary, Alligator Bioscience is a leading company in cancer research and therapy, with an innovative technology platform and highly specialized drugs that have shown promising results. The company is continuously working to develop new and better cancer therapies. Alligator Bioscience ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Alligator Bioscience's Employee Base

Alligator Bioscience's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Alligator Bioscience's operational capacity and future potential.

Year-to-Year Comparison

Assessing Alligator Bioscience's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Alligator Bioscience's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Alligator Bioscience’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Alligator Bioscience stock

How many employees does Alligator Bioscience have this year?

Alligator Bioscience has 43 undefined employees this year.

How many employees did Alligator Bioscience have compared to the previous year?

Compared to the previous year, Alligator Bioscience had 0% more employees.

What impact did the number of employees have on the company Alligator Bioscience?

The number of employees has a direct impact on the efficiency and productivity of Alligator Bioscience. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Alligator Bioscience?

The number of employees can also have an impact on investors of Alligator Bioscience, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Alligator Bioscience affect the company?

An increase in equity of Alligator Bioscience can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Alligator Bioscience's equity affect the company?

A reduction in equity of Alligator Bioscience can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Alligator Bioscience?

Some factors that can influence the equity of Alligator Bioscience include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Alligator Bioscience so important for investors?

The equity of Alligator Bioscience is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Alligator Bioscience influence the company?

The number of employees at Alligator Bioscience can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Alligator Bioscience evolved in recent years?

In recent years, the number of employees at Alligator Bioscience has changed by 0.

How many employees does Alligator Bioscience currently have?

Alligator Bioscience currently has 43 undefined employees.

Why is the number of employees important for investors of Alligator Bioscience?

The number of employees is important for investors of Alligator Bioscience as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Alligator Bioscience take to change the number of employees?

To change the number of employees, Alligator Bioscience can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Alligator Bioscience pay?

Over the past 12 months, Alligator Bioscience paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Alligator Bioscience is expected to pay a dividend of 0 SEK.

What is the dividend yield of Alligator Bioscience?

The current dividend yield of Alligator Bioscience is .

When does Alligator Bioscience pay dividends?

Alligator Bioscience pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Alligator Bioscience?

Alligator Bioscience paid dividends every year for the past 0 years.

What is the dividend of Alligator Bioscience?

For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.

In which sector is Alligator Bioscience located?

Alligator Bioscience is assigned to the 'Health' sector.

Wann musste ich die Aktien von Alligator Bioscience kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Alligator Bioscience from 9/13/2024 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 9/13/2024.

When did Alligator Bioscience pay the last dividend?

The last dividend was paid out on 9/13/2024.

What was the dividend of Alligator Bioscience in the year 2023?

In the year 2023, Alligator Bioscience distributed 0 SEK as dividends.

In which currency does Alligator Bioscience pay out the dividend?

The dividends of Alligator Bioscience are distributed in SEK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Alligator Bioscience

Our stock analysis for Alligator Bioscience Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Alligator Bioscience Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.